FDA Inspection
Exel Inc. d/b/a DHL Supply ChainExel Inc. d/b/a DHL Supply Chain – FDA Inspection, Mar 13, 2020
Record Details
This FDA Inspection record concerns Exel Inc. d/b/a DHL Supply Chain, with an inspection on March 13, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 13, 2020
- Product Type
- Drugs
View Company Profile
ID · 352526bf-b691-42fd-9633-ee6269b7a736
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1121726
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Exel Inc. d/b/a DHL Supply Chain
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 25, 2025 | Not classified | Philadelphia District Office |
Other documents for Exel Inc. d/b/a DHL Supply Chain
- FDA Inspection 1270208 - 2025-09-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.